Micro-fluidic chip and detection method thereof
By designing the whole blood processing area and sample detection area of the microfluidic chip, combining capillary channel and fluorescent microsphere labeling technology, low-cost multi-index detection is achieved, solving the high cost and difficulty of microfluidic chips in the existing technology. Problems with off-hospital testing are suitable for home testing.
Patent Information
- Application Number
- CN202310645284.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-01
- Publication Date
- 2024-12-03
AI Technical Summary
Existing microfluidic chips are costly and difficult to achieve off-hospital testing, and cannot meet the disease detection needs of multiple batch testing projects, especially specific IgG antibody detection is difficult to achieve home testing.
A microfluidic chip is designed, including a whole blood treatment area, sample reaction area, sample detection area and sample recovery area. The direct detection of whole blood samples is achieved through capillary channels and filters, and antibodies are labeled with fluorescent microspheres and captured antigens are captured. Implement multiple indicators simultaneous testing, suitable for home testing.
It realizes low-cost multi-indicator detection, simplifies the sample processing process, reduces the requirements of detection equipment, is suitable for accurate and rapid detection of whole blood samples, is suitable for home testing, and solves the problems of high cost and complex structure in the existing technology. .
Smart Images

Figure CN119056504A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biomedical technology, and in particular to a microfluidic chip and a detection method thereof. Background Art
[0002] Microfluidics chip technology integrates the basic operation units of biological, chemical and medical analysis processes such as sample reaction and detection into micrometer-scale chips to automatically complete the entire analysis process. The characteristics and development advantages of microfluidic chips are shown in: microfluidic chips have controllable liquid flow, consume very little sample and reagent (microfluidic chips can transmit 10 -6 L to 10 -15 L fluid), less waste liquid generated by analysis, and analysis speed increased by ten or even a hundred times. It can perform high-throughput analysis of hundreds of samples in a few minutes or even shorter time, and the cost is low, and the chip can be used once. The new generation of microfluidic chips are mainly made of inorganic rigid materials such as silicon wafers, polymer materials such as glass, quartz, epoxy resin, and elastic materials such as polyurea and polyurethane. Based on these materials, a variety of functional modules can be made, such as valves, fluid pumps, and fluid mixers, which can be concentrated in the microfluidic chip; at the same time, the functional modules can be connected to the computer, and the operation of the module can be controlled by computer programs. This integrated, CNC-controlled microfluidic chip can complete many complex operations.
[0003] However, most of the existing microfluidic chips can only detect a single indicator, and some microfluidic chips can achieve joint detection of a small number of indicators by adding channels. With each additional channel, the chip either becomes larger in overall size, the sample usage increases, and the production cost increases, or the spotting accuracy increases, the structure becomes more complex, the production cost increases, and the requirements for production and testing equipment are also higher. For disease detection that requires batch testing of multiple items, existing solutions are time-consuming and labor-intensive and require a high sample volume, and most current specific IgG antibody (immunoglobulin G) tests cannot meet the needs of home testing. Summary of the invention
[0004] The present invention provides a microfluidic chip and a detection method thereof, which are used to solve the defects of the prior art that the microfluidic chip is high in cost and difficult to realize out-of-hospital detection, and realizes that the microfluidic chip can be used for self-testing at home while being low in cost and detecting multiple indicators.
[0005] The present invention provides a microfluidic chip, comprising:
[0006] A substrate, wherein at least one microfluidic channel is provided on the substrate, one end of the substrate has a whole blood processing area, the microfluidic channels are all connected to the whole blood processing area and extend toward the other end of the substrate, the whole blood processing area is provided with a filter, and the filter is used to filter the sample in the whole blood processing area;
[0007] A sample adding hole is provided on the outer surface of the substrate, and the sample adding hole is connected to the whole blood processing area for adding samples to the whole blood processing area;
[0008] The microfluidic channel is provided with a sample reaction zone, a sample detection zone and a sample recovery zone in sequence along a direction away from the whole blood processing zone; the sample reaction zone is connected with the whole blood processing zone; the sample reaction zone is connected with the sample detection zone through a first capillary channel; and the sample detection zone is connected with the sample recovery zone through a second capillary channel.
[0009] According to a microfluidic chip provided by the present invention, the whole blood processing area has a whole blood processing chamber, the filter element is a blood filter membrane, and the blood filter membrane is used to filter the sample entering the whole blood processing chamber from the sample addition hole.
[0010] According to a microfluidic chip provided by the present invention, the sample reaction area is coated with a labeled antigen labeled with a signal particle or a labeled antibody labeled with a signal particle, and the labeled antigen or labeled antibody specifically reacts with the antibody or antigen in the sample to form a complex.
[0011] According to a microfluidic chip provided by the present invention, the sample detection area is preset with a plurality of different capture antigens or capture antibodies, and the capture antigens or the capture antibodies are used to capture the complex formed in the sample reaction area.
[0012] According to a microfluidic chip provided by the present invention, the sample detection area is arranged in a curved disc shape along a flow path from the sample reaction area toward the sample recovery area, and a plurality of different capture antigens or capture antibodies are arranged along the flow direction of the flow path.
[0013] According to a microfluidic chip provided by the present invention, the first capillary channel and the second capillary channel are both arranged in a curved stacked shape.
[0014] According to a microfluidic chip provided by the present invention, the microfluidic chip further comprises a third capillary channel, the third capillary channel is connected between the whole blood processing area and the sample reaction area, and the third capillary channel is arranged in a curved disc shape.
[0015] According to a microfluidic chip provided by the present invention, the signal particles include at least one of fluorescent microspheres, colloidal gold, visualized fluorescent microspheres, magnetic microparticles, latex microparticles, luminol, and acridinium ester.
[0016] According to a microfluidic chip provided by the present invention, the sample recovery area is provided with a water-absorbing material, and the water-absorbing material is used to collect the sample remaining after being captured in the sample detection area.
[0017] The present invention also provides a detection method using the above-mentioned microfluidic chip, comprising the following steps:
[0018] Step S1: dripping the sample to be tested from the sample addition hole;
[0019] Step S2: After the sample is added in step S1, if the added sample is a whole blood sample, the sample flows in the microfluidic channel by capillary action, and first passes through the whole blood processing area to filter the sample so that the red blood cells in the sample are removed; if the added sample is serum or plasma, it also passes through the whole blood processing area, but the filter element does not interfere with the reaction of the sample;
[0020] Step S3: the sample filtered in step S2 flows to the sample reaction zone under capillary action: the sample reaction zone contains secondary antibodies labeled with fluorescent microspheres, which react specifically with various human anti-allergen IgG antibodies in the sample to form a variety of antibody-secondary antibody-fluorescent microsphere complexes;
[0021] Step S4: As the sample continues to flow, the various antibody-secondary antibody-fluorescent microsphere complexes leave the sample reaction area and arrive at the sample detection area, and are captured by the corresponding various capture antigens on the flow path in the sample detection area;
[0022] Step S5: the remaining samples continue to flow until they are collected by the sample recovery area;
[0023] Step S6: After the reaction of step S4 is complete, the microfluidic chip is inserted into a fluorescent immunoassay analyzer: the antigen-antibody-secondary antibody-fluorescent microsphere complex adsorbed in the sample detection area generates a fluorescent signal under the stimulation of an external light source, and the fluorescent immunoassay analyzer can detect the intensity of the fluorescent signal and automatically calculate the concentration of the corresponding specific antibody in the sample according to the pre-set calibration curve.
[0024] The present invention provides a microfluidic chip, which obtains a blood sample of whole blood by relying on a microneedle or a blood collection needle. After the blood sample is dripped into the whole blood processing area through the sample addition hole, the blood sample flows in the microfluidic channel by its own capillary action, first passes through the whole blood processing area, and filters the blood cells in the whole blood sample through the filter element; the remaining blood sample flows into the sample reaction area, and specific reactions occur in the sample reaction area to form multiple complexes; the complexes continue to flow with the blood sample and are captured when they reach the sample detection area; and the remaining other blood samples continue to flow until they are fully recovered by the sample recovery area. In this way, by utilizing whole blood filtration technology, whole blood samples can be directly tested, avoiding the complicated sample processing process. At the same time, by utilizing the precise control of microfluidics and microscale fluid manipulation, accurate and rapid detection of trace samples can be achieved. By designing that each chamber or channel in the sample detection area contains multiple different capture antigens or capture antibodies, an increase in detection indicators can be achieved, thereby achieving simultaneous detection of multiple indicators with a smaller sample amount, a simpler structure, and a smaller volume, and there are few restrictions on detection equipment. Whole blood samples are also suitable for home testing. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the following briefly introduces the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0026] Figure 1 It is a structural schematic diagram of an embodiment of a microfluidic chip provided by the present invention;
[0027] Figure 2 is a structural schematic diagram of another embodiment of the microfluidic chip provided by the present invention;
[0028] Figure 3 It is a flow chart of the detection method of the microfluidic chip provided by the present invention.
[0029] Reference numerals:
[0030] 100, microfluidic chip; 110, substrate; 120, whole blood processing area; 130, sample addition hole; 140, sample reaction area; 150, sample detection area; 151, capture antigen; 152, capture antibody; 160, sample recovery area; 170, first capillary channel; 180, second capillary channel; 190, third capillary channel. DETAILED DESCRIPTION
[0031] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be clearly and completely described below in conjunction with the drawings of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0032] In the description of the embodiments of the present invention, it should be noted that, unless otherwise expressly specified and limited, the terms "first" and "second" are for the purpose of clearly explaining the numbering of product components and do not represent any substantial difference. The directions of "up" and "down" shall be based on the directions shown in the accompanying drawings. For ordinary technicians in this field, the specific meanings of the above terms in the embodiments of the present invention can be understood according to the specific circumstances. In addition, the meaning of "multiple" is two or more. "And / or" in the specification and claims means at least one of the connected objects, and the character " / " generally indicates that the previously associated objects are in an "or" relationship.
[0033] In the description of the present invention, it should be noted that, unless otherwise clearly specified and limited, the terms "installed", "connected" and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be indirectly connected through an intermediate medium, or it can be the internal communication of two components. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0034] The invention provides a microfluidic chip and a detection method thereof.
[0035] In the embodiment of the present invention, Figure 1 to Figure 2 As shown, the microfluidic chip 100 includes a substrate 110, on which at least one microfluidic channel is provided, one end of the substrate 110 has a whole blood processing area 120, the microfluidic channels are all connected to the whole blood processing area 120 and extend toward the other end of the substrate 110, the whole blood processing area 120 is provided with a filter, and the filter is used to filter the sample in the whole blood processing area 120; a sample addition hole 130 is provided on the facade of the substrate 110, and the sample addition hole 130 is connected to the whole blood processing area 120 for adding samples to the whole blood processing area 120; the microfluidic channel is sequentially provided with a sample reaction area 140, a sample detection area 150 and a sample recovery area 160 in a direction away from the whole blood processing area 120, the sample reaction area 140 is connected to the whole blood processing area 120, the sample reaction area 140 is connected to the sample detection area 150 through a first capillary channel 170, and the sample detection area 150 is connected to the sample recovery area 160 through a second capillary channel 180.
[0036] In an embodiment of the present invention, the microfluidic chip 100 includes a substrate 110. The material of the substrate 110 includes but is not limited to glass, resin, polydimethylsiloxane, polymethyl methacrylate, polypropylene, polyethylene terephthalate, polycarbonate, paper, etc. The substrate 110 is roughly arranged in a straight plate-like structure, and the substrate 110 is used to provide a carrier for other components of the microfluidic chip 100.
[0037] The present invention provides a microfluidic chip 100. After a sample (including a whole blood, serum or plasma sample) is dripped into a whole blood processing area 120 through a sample addition hole 130, the sample flows in a microfluidic channel by its own capillary action, first passes through the whole blood processing area 120, and blood cells (if any) in the sample are filtered by a filter element; the remaining sample flows into a sample reaction area 140, where a specific reaction occurs to form a variety of complexes; the complexes continue to flow with the sample and are captured when they reach a sample detection area 150; and the remaining other samples continue to flow until they are fully recovered by a sample recovery area 160. In this way, by utilizing whole blood filtration technology, whole blood samples can be directly tested, avoiding the complicated sample processing process. At the same time, by utilizing the precise control of microfluidics and microscale fluid manipulation, accurate and rapid detection of trace samples can be achieved. By designing that each chamber or channel of the sample detection area 150 contains multiple different capture antigens or capture antibodies, an increase in detection indicators is achieved, thereby achieving simultaneous detection of multiple indicators with a smaller sample amount, a simpler structure, and a smaller volume, and there are few restrictions on detection equipment. In addition, whole blood samples are suitable for home testing.
[0038] In one embodiment, the whole blood processing area 120 has a whole blood processing chamber, and the filter element is a blood filter membrane, which is used to filter the whole blood sample entering the whole blood processing chamber from the sample addition hole 130. It can be understood that in order to facilitate the short stay of the sample dripped into the whole blood processing area 120 to provide filtering time for the subsequent blood filter membrane, the present application sets a whole blood processing chamber, and in other embodiments, it can also be a sink trough type setting, but it is not limited to this; the blood filter membrane is used to filter the blood cells in the whole blood sample to eliminate the interference of blood cells on the detection. Of course, in other embodiments, the filter element can also be set as other sieve structures to separate blood cells. In this way, using the whole blood filtration technology, the whole blood (including fingertip blood) sample can be directly detected, avoiding complicated sample processing, and solving the problem of difficult venous blood collection in children in clinical practice. Specifically, in the embodiment of the present invention, the microfluidic chip 100 can be used to process whole blood samples, plasma or serum samples, that is, the sample can include whole blood samples, plasma samples or serum samples, etc. The presence of the filter will not interfere with the detection of serum samples and plasma samples in the microfluidic chip 100, thereby expanding the application of the microfluidic chip 100.
[0039] Reference Figure 1, the sample reaction area 140 is coated with a labeled antigen labeled with a signal particle or a labeled antibody labeled with a signal particle, and the labeled antigen or labeled antibody reacts specifically with the antibody or antigen in the sample to form a complex. Specifically, the signal particles include at least one of fluorescent microspheres, colloidal gold, visualized fluorescent microspheres, magnetic particles, latex particles, luminol, and acridinium esters. If the signal particles are replaced with colloidal gold, they can be visually observed or interpreted in combination with a mobile phone auxiliary reading software, and the signal particles are replaced. This application is explained using the signal particles as fluorescent microspheres as an example, and other embodiments can be implemented with reference to this embodiment. The sample reaction area 140 is coated with a labeled antibody or labeled antigen labeled with fluorescent microspheres, and the labeled labeled antibody or labeled antigen can react specifically with the antigen or antibody in the sample to form a complex. The formed complex continues to flow out of the sample reaction area 140 with the sample and is captured when it reaches the sample detection area 150. A capillary channel with an S-shape bend is designed at the end of the sample reaction area 140. The flow rate of the sample is adjusted by controlling the size and length of the capillary channel to ensure the reaction time of the sample in the sample reaction area 140. Due to the advantages of low cost and high sensitivity of fluorescent microspheres, accurate detection is achieved while reducing the cost of reagents and supporting equipment. Among them, the antigen / antibody is not limited by species origin, and the antibody can be a secondary antibody. In this way, through the combination of protein dot matrix technology and microfluidic technology, under the same chip volume, the present application can realize the possibility of detecting more than a dozen or even more indicators in the chip at the same time. It solves the problem that the current microfluidic chip 100 joint inspection can only detect a few indicators due to technical difficulties such as chip volume and spotting accuracy.
[0040] Specifically, the fluorescent microspheres may be labeled with antibodies or antigens, the detection markers may be antigens or antibodies, and the sample detection area 150 may be coated with capture antibodies 152 or capture antigens 151. Depending on the fluorescent microsphere markers, detection markers, and substances coated with the sample detection area 150, the reaction principle may be double antibody sandwich, double antigen sandwich, indirect method, competitive method, capture method, etc.
[0041] Reference Figure 1 and Figure 2In some embodiments, the sample detection area 150 is preset with a plurality of different capture antigens 151 or capture antibodies 152, and the capture antigens 151 or capture antibodies 152 are used to capture the complex formed in the sample reaction area 140. It can be understood that the sample detection area of the present application is arranged behind the sample reaction area along the microfluidic channel path, and a plurality of different capture antibodies 152 or capture antigens 151 are pre-embedded on the solid phase carrier of the sample detection area 150, and the position of the capture antibody 152 or capture antigen 151 is fixed and does not leave the sample detection area 150 with the flow of the sample. Optionally, a plurality of capture antigens 151 or capture antibodies 152 can be pre-embedded in a sample detection area 150 at the same time to avoid too low a sample amount due to liquid separation, thereby improving the requirements for spotting accuracy in the production process, and at the same time, by setting a smaller number of sample detection areas 150, the detection of multiple markers can be completed to avoid an increase in the chip volume.
[0042] Reference Figure 1 Furthermore, the sample detection area 150 is arranged in a curved coiled shape along the flow path from the sample reaction area 140 to the sample recovery area 160, and a plurality of different capture antigens 151 or capture antibodies 152 are arranged along the flow direction of the flow path. In this way, the pre-embedded area of the capture antigens 151 or capture antibodies 152 is increased, the preset number of capture antigens 151 or capture antibodies 152 is increased, and the reaction time of the capture antigens 151 or capture antibodies 152 is increased, so that the sample can be fully reacted in the sample detection area 150.
[0043] Of course, in other embodiments, the sample detection area 150 may also be vertically disposed, and is not limited thereto.
[0044] Reference Figure 1 , the first capillary channel 170 and the second capillary channel 180 are both arranged in a curved disc-like shape. The present application drives the sample to flow in the microfluidic channel by capillary action by arranging the first capillary channel 170 and the second capillary channel 180. At the same time, the flow rate can be adjusted by controlling the size and length of the capillary channel to ensure the reaction time of the sample in the sample reaction area 140 and the sample detection area 150. At the same time, the first capillary channel 170 and the second capillary channel 180 are both arranged in a curved disc-like shape, thereby reducing the volume of the first capillary channel 170 and the second capillary channel 180 occupied by the substrate 110, so as to reduce the volume of the substrate 110, thereby reducing the volume of the microfluidic chip 100. Of course, in other embodiments, the power for driving the sample flow can also be replaced by air pressure, centrifugation, voltage, magnetic force, etc.
[0045] Reference Figure 2Further, the microfluidic chip 100 also includes a third capillary channel 190, which is connected between the whole blood processing area 120 and the sample reaction area 140, and the third capillary channel 190 is arranged in a curved disc shape. It can be understood that when the microfluidic chip includes multiple microfluidic channels, in order to facilitate the precise control of the sample flow in each microfluidic channel, the third capillary channel 190 is arranged in the whole blood processing area 120 and the sample reaction area 140. Of course, in other embodiments, the whole blood processing area 120 and the sample reaction area 140 can also be arranged in other forms of connection, which are not particularly limited here.
[0046] In some embodiments, the sample recovery area 160 is provided with a water-absorbing material, and the water-absorbing material is used to collect the sample remaining after the sample detection area 150 is captured. It can be understood that the present application recovers the sample remaining from the sample detection area 150 by providing a water-absorbing material in the sample recovery area 160 to prevent the sample from flowing back and polluting the environment. Optionally, the water-absorbing material can also be a water-absorbing pad, etc. It should be understood that the water-absorbing material can also be any other suitable component with a water-absorbing function.
[0047] On the other hand, refer to Figure 3 The present invention also provides a detection method using the above-mentioned microfluidic chip 100, comprising the following steps:
[0048] Step S1: dripping the serum, plasma or whole blood sample to be tested from the sample injection hole 130;
[0049] Step S2: After the sample is added in step S1, if the added sample is whole blood, the sample flows in the microfluidic channel by capillary action, and first passes through the whole blood processing area 120 to filter the sample so that the red blood cells in the sample are removed; if the added sample is serum or plasma, it also passes through the whole blood processing area 120, but the filter element does not interfere with the reaction of the sample;
[0050] Step S3: The sample filtered in step S2 flows to the sample reaction area 140 under capillary action: the sample reaction area 140 contains a secondary antibody labeled with fluorescent microspheres, which specifically reacts with the human anti-allergen IgG antibody in the sample to form an antibody-secondary antibody-fluorescent microsphere complex;
[0051] Step S4: As the sample continues to flow, the antibody-secondary antibody-fluorescent microsphere complex leaves the sample reaction area 140 and reaches the sample detection area 150 , and is captured by the capture antigen 151 in the sample detection area 150 ;
[0052] Step S5: the remaining samples continue to flow until they are collected by the sample recovery area 160;
[0053] Step S6: After the reaction of step S4 is complete, the microfluidic chip 100 is inserted into the fluorescent immunoassay analyzer: the antigen-antibody-secondary antibody-fluorescent microsphere complex adsorbed on the sample detection area 150 generates a fluorescent signal under the stimulation of an external light source, and the fluorescent immunoassay analyzer can detect the intensity of the fluorescent signal and automatically calculate the concentration of the corresponding specific antibody in the corresponding sample according to the pre-set calibration curve.
[0054] The specific embodiments are as follows:
[0055] The design of the microfluidic chip 100 is as follows:
[0056] The whole blood processing area 120 is placed below the sample loading hole 130 and separates blood cells through a filter element;
[0057] Anti-human IgG antibodies were labeled with fluorescent microspheres and pre-embedded in the chip reaction area;
[0058] Antibiotics such as beef, milk, chicken, eggs, pork, cod, shrimp, crab, mushroom, tomato, wheat, corn, rice, and soybean are respectively embedded in the sample detection area using a spotting instrument and then dried.
[0059] Add absorbent paper to the sample recovery area 160 to fully absorb the excess sample to prevent the sample from flowing back and polluting the environment.
[0060] The microfluidic chip 100 is applied to the detection of specific IgG antibodies using an indirect method, and the reaction process principle is as follows:
[0061] Drop the sample (serum, plasma or whole blood) into the sample well 130;
[0062] After the sample is added, the sample is driven to flow in the microfluidic channel by the capillary action of the sample itself, first passing through the whole blood processing area 120, and then filtered through the blood filter membrane to remove the red blood cells (if any) in the sample;
[0063] The filtered sample flows to the sample reaction area 140. The sample reaction area 140 contains a secondary antibody (anti-human IgG antibody) labeled with fluorescent microspheres, which specifically reacts with the human anti-allergen IgG antibody in the flowing sample to form an antibody-secondary antibody-fluorescent microsphere complex;
[0064] As the sample flows, the antibody-secondary antibody-fluorescent microsphere complex leaves the sample reaction area 140 and reaches the sample detection area 150 , and is captured by the antigen (allergen) coated in the sample detection area 150 ;
[0065] The remaining sample continues to flow until it is fully absorbed by the absorbent paper in the sample recovery area 160;
[0066] After the reaction is complete, the test paper card of the microfluidic chip 100 is inserted into the fluorescent immunoassay analyzer. The antigen-antibody-secondary antibody-fluorescent microsphere complex adsorbed on the sample detection area 150 generates a signal under the stimulation of an external light source, and the fluorescent immunoassay analyzer can detect the intensity of the fluorescent signal and automatically calculate the concentration of the corresponding specific antibody in the corresponding sample according to the pre-set calibration curve.
[0067] The detection operation steps of the microfluidic chip 100 are as follows:
[0068] First, a sample is obtained, which may include a whole blood, serum, or plasma sample;
[0069] Then, the sample is dripped into the sample adding hole 130 of the substrate 110 , and after waiting for 15 minutes, the microfluidic chip 100 is inserted into the fluorescent immunoassay analyzer for detection.
[0070] In the embodiments of the present invention, unless otherwise clearly specified and limited, the first feature being "above" or "below" the second feature may mean that the first and second features are in direct contact, or the first and second features are in indirect contact through an intermediate medium. Moreover, the first feature being "above", "above" and "above" the second feature may mean that the first feature is directly above or obliquely above the second feature, or simply means that the first feature is higher in level than the second feature. The first feature being "below", "below" and "below" the second feature may mean that the first feature is directly below or obliquely below the second feature, or simply means that the first feature is lower in level than the second feature.
[0071] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the embodiment of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.
[0072] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A microfluidic chip, characterized in that: include: A substrate, wherein at least one microfluidic channel is provided on the substrate, one end of the substrate has a whole blood processing area, the microfluidic channels are all connected to the whole blood processing area and extend toward the other end of the substrate, the whole blood processing area is provided with a filter, and the filter is used to filter the sample in the whole blood processing area; A sample adding hole is provided on the outer surface of the substrate, and the sample adding hole is connected to the whole blood processing area for adding samples to the whole blood processing area; The microfluidic channel is provided with a sample reaction zone, a sample detection zone and a sample recovery zone in sequence along a direction away from the whole blood processing zone; the sample reaction zone is connected with the whole blood processing zone; the sample reaction zone is connected with the sample detection zone through a first capillary channel; and the sample detection zone is connected with the sample recovery zone through a second capillary channel.
2. The microfluidic chip according to claim 1, characterized in that: The whole blood processing area has a whole blood processing chamber, and the filter element is a blood filter membrane, which is used to filter the sample entering the whole blood processing chamber from the sample addition hole.
3. The microfluidic chip according to claim 1, characterized in that: The sample reaction area is coated with a labeled antigen labeled with a signal particle or a labeled antibody labeled with a signal particle, and the labeled antigen or labeled antibody reacts specifically with the antibody or antigen in the sample to form a complex.
4. The microfluidic chip according to claim 3, characterized in that: The sample detection area is preset with a plurality of different capture antigens or capture antibodies, and the capture antigens or the capture antibodies are used to capture the complex formed in the sample reaction area.
5. The microfluidic chip according to claim 4, characterized in that: The sample detection area is arranged in a curved, stacked shape along a flow path from the sample reaction area toward the sample recovery area, and a plurality of different capture antigens or capture antibodies are arranged along the flow direction of the flow path.
6. The microfluidic chip according to any one of claims 1 to 5, characterized in that: The first capillary channel and the second capillary channel are both arranged in a bent and stacked shape.
7. The microfluidic chip according to any one of claims 1 to 5, characterized in that: The microfluidic chip further comprises a third capillary channel, wherein the third capillary channel is connected between the whole blood processing area and the sample reaction area, and the third capillary channel is arranged in a bent disc shape.
8. The microfluidic chip according to claim 3, characterized in that: The signal particles include at least one of fluorescent microspheres, colloidal gold, visualized fluorescent microspheres, magnetic microparticles, latex microparticles, luminol, and acridinium ester.
9. The microfluidic chip according to any one of claims 1 to 5, characterized in that: The sample recovery area is provided with a water-absorbing material, and the water-absorbing material is used to collect the remaining sample after being captured by the sample detection area.
10. A detection method using the microfluidic chip described in any one of claims 1 to 9, characterized in that: The steps include: Step S1: dripping the sample to be tested from the sample addition hole; Step S2: After the sample is added in step S1, if the added sample is a whole blood sample, the sample flows in the microfluidic channel by capillary action, and first passes through the whole blood processing area to filter the sample so that the red blood cells in the sample are removed; if the added sample is serum or plasma, it also passes through the whole blood processing area, but the filter element does not interfere with the reaction of the sample; Step S3: the sample filtered in step S2 flows to the sample reaction zone under capillary action: the sample reaction zone contains a secondary antibody labeled with fluorescent microspheres, which specifically reacts with the human anti-allergen IgG antibody in the sample to form an antibody-secondary antibody-fluorescent microsphere complex; Step S4: As the sample continues to flow, the antibody-secondary antibody-fluorescent microsphere complex leaves the sample reaction area and reaches the sample detection area, and is captured by the capture antigen in the sample detection area; Step S5: the remaining samples continue to flow until they are collected by the sample recovery area; Step S6: After the reaction of step S4 is complete, the microfluidic chip is inserted into a fluorescent immunoassay analyzer: the antigen-antibody-secondary antibody-fluorescent microsphere complex adsorbed in the sample detection area generates a fluorescent signal under the stimulation of an external light source, and the fluorescent immunoassay analyzer can detect the intensity of the fluorescent signal and automatically calculate the concentration of the corresponding specific antibody in the sample according to the pre-set calibration curve.
Citation Information
Patent Citations
Microfluidic chip for fluorescence immunity detection and production method of micro-fluidic chip
CN106807461A
Micro-fluidic chip based on fluorescence immunoassay joint detection as well as preparation method and application of micro-fluidic chip
CN108181458A
Micro-fluidic chip and immunofluorescence analyzer
CN108704680A
Micro-fluidic chip, detection kit, micro-fluidic detection system and application thereof
CN111426847A
Shared sample injection microfluidic immunoassay joint inspection device
CN111665354A
Cited By
Biological detection chip, detection method and detection equipment
CN119738236A
Microfluid sample detection method
CN119804846A
